Epidemiology

Home

Pages

Diabetes and endocrinology

Hypercalcaemia

Add annotation to this page

Authoring team

Overall incidence of hypercalcaemia is estimate to be around 0.6% (1)

The estimated incidence of hypercalcaemia caused by

primary hyperparathyroidism - 250 cases per million

malignancy - 150 cases per million population (1)

Hypercalcaemia was observed in 10-60% of patients on long term Lithium therapy (2)

 Alberta Medical Association 2008. Alberta Clinical Practice Guidelines. Laboratory endocrine testing guidelines: hypercalcemia.

Jones BJ, Twomey PJ. Requesting patterns for serum calcium concentration in patients on long-term lithium therapy. Int J Clin Pract. 2009;63(1):170-2

Annotations let you add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. Reflective notes let you add information to the CPD dashboard based on the content of this page: what did you learn from it and how might it change your practice?

Annotations let you add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

Epidemiology

Create an account to add page annotations